IL37 and psoriasis: It has been reported that TRPV1+ and Nav1.8+ nociceptors were necessary factors to drive imiquimod (IMQ) induced psoriasis-like inflammation in skin by promoting dermal dendritic cells (dDCs) to produce Interleukin 23 (IL-23).